Literature DB >> 17928161

Alzheimer's disease as copper deficiency.

Leslie M Klevay1.   

Abstract

Four classes of etiologic agents can produce toxic, hereditary, infectious and deficiency diseases. Recent research on Alzheimer's disease generally addresses pathogenesis related to the first three classes of agents with little emphasis on cause. Low copper and cytochrome oxidase in Alzheimer brain can be attributed to low copper intakes or higher than average nutritional requirements. Experiments with animals deficient in copper involving amyloid, ceruloplasmin, copper transport, cytochrome oxidase, myelination, organ analysis and oxidative defense are consonant. Decreased cognition and increased tau in cerebrospinal fluid in Alzheimer's disease also are associated with low copper status. A high requirement for copper may explain early onset of Alzheimer's disease in Down's syndrome. Copper deficiency is a plausible cause of Alzheimer's disease. This hypothesis should be tested with a lengthy trial of copper supplementation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928161     DOI: 10.1016/j.mehy.2007.04.051

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  14 in total

Review 1.  The role of insufficient copper in lipid synthesis and fatty-liver disease.

Authors:  Austin Morrell; Savannah Tallino; Lei Yu; Jason L Burkhead
Journal:  IUBMB Life       Date:  2017-03-08       Impact factor: 3.885

Review 2.  Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Sonia Zaman; Yesmin Begum; Ghulam Md Ashraf; May N Bin-Jumah; Simona G Bungau; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-05       Impact factor: 5.590

3.  Issues raised involving the copper hypotheses in the causation of Alzheimer's disease.

Authors:  George J Brewer
Journal:  Int J Alzheimers Dis       Date:  2011-09-14

4.  Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies.

Authors:  Anthony Samsel; Stephanie Seneff
Journal:  Surg Neurol Int       Date:  2015-03-24

5.  Alzheimer's disease causation by copper toxicity and treatment with zinc.

Authors:  George J Brewer
Journal:  Front Aging Neurosci       Date:  2014-05-16       Impact factor: 5.750

6.  Spatial memory deficits in a mouse model of late-onset Alzheimer's disease are caused by zinc supplementation and correlate with amyloid-beta levels.

Authors:  Jane M Flinn; P Lorenzo Bozzelli; Paul A Adlard; Angela M Railey
Journal:  Front Aging Neurosci       Date:  2014-10-22       Impact factor: 5.750

Review 7.  Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.

Authors:  Oddvar Myhre; Hans Utkilen; Nur Duale; Gunnar Brunborg; Tim Hofer
Journal:  Oxid Med Cell Longev       Date:  2013-04-17       Impact factor: 6.543

8.  Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction.

Authors:  Alan Rembach; Dominic J Hare; Monica Lind; Christopher J Fowler; Robert A Cherny; Catriona McLean; Ashley I Bush; Colin L Masters; Blaine R Roberts
Journal:  Int J Alzheimers Dis       Date:  2013-10-21

9.  Reciprocal modulation of Aβ42 aggregation by copper and homocysteine.

Authors:  Salla Keskitalo; Melinda Farkas; Michael Hanenberg; Anita Szodorai; Luka Kulic; Alexander Semmler; Michael Weller; Roger M Nitsch; Michael Linnebank
Journal:  Front Aging Neurosci       Date:  2014-09-08       Impact factor: 5.750

Review 10.  Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.

Authors:  Yong Li; Qian Jiao; Huamin Xu; Xixun Du; Limin Shi; Fengju Jia; Hong Jiang
Journal:  Front Mol Neurosci       Date:  2017-10-24       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.